Orikine
orikine.bio
Actively hiring
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
201-500
employees, estimated range
Backers
1
Asabys Partners
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 8
New executive Orikine appoints new CEO and Leadership Team to advance ORK1 in Autoimmune Disease · YahooFinance
2022
Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Asabys Partners Similar startupsby what they do, their industry and backers
First purpose-built, minimally invasive, ultrasound-based system designed to treat patients with pulmonary hypertension due to left-sided…
Search for: At SonomaBio we believe in balance. Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered…
Protein Splicing to Develop the Next Generation of Genetic Medicines.
Lipum is a biopharmaceutical company specialized on a novel way to treat chronic inflammatory diseases.
Follow us on our mission to treat fibrosis and restore organ function in multiple therapeutic areas.
A biotech company developing better medicines for patients with autoimmune and inflammatory diseases. Leveraging powerful insights into the…
Overview
Precision-engineered, bi-specific cytokines to treat autoimmune and inflammatory diseases. Highly versatile protein-design platform to develop optimal cytokine therapeutics that can deliver the desired signalling to the desired cell and/or tissue to achieve a maximum in efficacy and safety.
News
A&As: Actithera, Callio, Pyxis, Orikine name new CEOs
New hires and promotions in the biopharma and med-tech industries, including: Actithera, Adapthealth, Alchemab, Alterome, Cadwell, Callio, Candel, Carlsmed, Century, CPTx, Cytospire, Dexcom, Editas, Electra, Electrocore, Flare, Icentia, Immunogenesis, In8
Read more
Report
Orikine appoints new CEO and Leadership Team to advance ORK1 in Autoimmune Disease
Sabrina Kuttruff-Coqui appointed Chief Executive Officer, Joachim Koch appointed Chief Scientific and Development Officer and Andreas Muehler join...
Read more
Report
Orikine appoints new CEO and Leadership Team to advance ORK1 in Autoimmune Disease
Sabrina Kuttruff-Coqui appointed Chief Executive Officer, Joachim Koch appointed Chief Scientific and Development Officer and Andreas Muehler joining as Chief Medical OfficerExpanded leadership team brings decades of expertise in translating scientific in
Read more
Report
Orikine Bio advances ORK-1 for inflammatory bowel disease
Orikine Bio SL is advancing lead candidate ORK-1 toward an IND submission and first-in-human studies for inflammatory bowel disease.
Read more
Report
Orikine capta 5,5 millones de Sabadell Asabys y AdBio
Los fondos Sabadell Asabys y AdBio han invertido 5,5 millones de euros en Orikine Bio, una biotec fundada el año pasado como spin-off del Centre de Regulació Genòmica
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Barcelona
Spain
Registered seat
08028 Barcelona, Spain
200-500 est. staff
2nd Floor, 08039 Barcelona, Spain